Identifying diagnostic and prognostic factors in cerebral amyloid angiopathy-related inflammation: A systematic analysis of published and seven new cases

被引:4
|
作者
Szalardy, Levente [1 ,2 ,3 ]
Fakan, Bernadett [1 ]
Maszlag-Torok, Rita [1 ]
Ferencz, Emil [1 ]
Reisz, Zita [4 ,5 ]
Radics, Bence L. [4 ]
Csizmadia, Sandor [6 ]
Szpisjak, Laszlo [1 ]
Annus, Adam [1 ]
Zadori, Denes [1 ]
Kovacs, Gabor G. [2 ,3 ,7 ,8 ]
Klivenyi, Peter [1 ]
机构
[1] Univ Szeged, Albert Szent Gyorgy Clin Ctr, Albert Szent Gyorgy Med Sch, Dept Neurol, Semmelweis U 6, H-6725 Szeged, Hungary
[2] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada
[3] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON, Canada
[4] Univ Szeged, Inst Pathol, Fac Med, Albert Szent Gyorgy Clin Ctr, Szeged, Hungary
[5] Kings Coll Hosp London, Dept Clin Neuropathol, London, England
[6] Affidea Hungary Ltd, Budapest, Hungary
[7] Univ Hlth Network, Lab Med Program, Toronto, ON, Canada
[8] Univ Hlth Network, Krembil Brain Inst, Toronto, ON, Canada
关键词
amyloid-beta-related angiitis; cerebral amyloid angiopathy; cerebral amyloid angiopathy-related inflammation; criteria; diagnosis; inflammatory cerebral amyloid angiopathy; outcome; predictor; BETA-RELATED ANGIITIS; CENTRAL-NERVOUS-SYSTEM; IMAGING ABNORMALITIES; CEREBROSPINAL-FLUID; APOLIPOPROTEIN-E; GRANULOMATOUS-ANGIITIS; ALZHEIMER-DISEASE; 63-YEAR-OLD MAN; ASSOCIATION; CAA;
D O I
10.1111/nan.12946
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Aims: Cerebral amyloid angiopathy (CAA)-related inflammation (CAA-RI) is a potentially reversible manifestation of CAA, histopathologically characterised by transmural and/or perivascular inflammatory infiltrates. We aimed to identify clinical, radiological and laboratory variables capable of improving or supporting the diagnosis of or predicting/influencing the prognosis of CAA-RI and to retrospectively evaluate different therapeutic approaches. Methods: We present clinical and neuroradiological observations in seven unpublished CAA-RI cases, including neuropathological findings in two definite cases. These cases were included in a systematic analysis of probable/definite CAA-RI cases published in the literature up to 31 December 2021. Descriptive and associative analyses were performed, including a set of clinical, radiological and laboratory variables to predict short-term, 6-month and 1-year outcomes and mortality, first on definite and second on an expanded probable/definite CAA-RI cohort. Results: Data on 205 definite and 100 probable cases were analysed. CAA-RI had a younger symptomatic onset than non-inflammatory CAA, without sex preference. Transmural histology was more likely to be associated with the co-localisation of microbleeds with confluent white matter hyperintensities on magnetic resonance imaging (MRI). Incorporating leptomeningeal enhancement and/or sulcal non-nulling on fluid-attenuated inversion recovery (FLAIR) enhanced the sensitivity of the criteria. Cerebrospinal fluid pleocytosis was associated with a decreased probability of clinical improvement and longer term positive outcomes. Future lobar haemorrhage was associated with adverse outcomes, including mortality. Immunosuppression was associated with short-term improvement, with less clear effects on long-term outcomes. The superiority of high-dose over low-dose corticosteroids was not established. Conclusions: This is the largest retrospective associative analysis of published CAA-RI cases and the first to include an expanded probable/definite cohort to identify diagnostic/prognostic markers. We propose points for further crystallisation of the criteria and directions for future prospective studies.
引用
收藏
页数:19
相关论文
共 50 条
  • [41] Enhancing Cerebral Amyloid Angiopathy-Related Inflammation Diagnosis With PET Using Pittsburgh Compound B
    Adaniya, Shinobu
    Matsuda, Hiroshi
    Tomori, Masaki
    Kaneko, Chikako
    Tomura, Noriaki
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (06) : e281 - e283
  • [42] Cerebral amyloid angiopathy-related inflammation: imaging findings and clinical outcome
    Matia Martucci
    Silvana Sarria
    Manuel Toledo
    Pilar Coscojuela
    Carla Vert
    Sahyly Siurana
    Cristina Auger
    Alex Rovira
    Neuroradiology, 2014, 56 : 283 - 289
  • [43] Cerebral Amyloid Angiopathy-Related Inflammation (CAA-ri): Presentation at an Unusual Age
    Zuniga, Diego
    Zuniga, Gabriel
    Hincapie, Sofia
    Salazar, Erin
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (07)
  • [44] Cerebral amyloid angiopathy-related inflammation: current status and future implications
    Wu Juan-Juan
    Yao Ming
    Ni Jun
    中华医学杂志英文版, 2021, 134 (06) : 646 - 654
  • [45] Slightly Symptomatic Cerebral Amyloid Angiopathy-Related Inflammation with Spontaneous Remission in Four Months
    Tetsuka, Syuichi
    Hashimoto, Ritsuo
    CASE REPORTS IN NEUROLOGICAL MEDICINE, 2019, 2019
  • [46] Anti-amyloid β autoantibodies in cerebral amyloid angiopathy-related inflammation: Implications for amyloid-modifying therapies
    Piazza, Fabrizio
    Greenberg, Steven M.
    Savoiardo, Mario
    Gardinetti, Margherita
    Chiapparini, Luisa
    Raicher, Irina
    Nitrini, Ricardo
    Sakaguchi, Hideya
    Brioschi, Monica
    Billo, Giuseppe
    Colombo, Antonio
    Lanzani, Francesca
    Piscosquito, Giuseppe
    Carriero, Maria Rita
    Giaccone, Giorgio
    Tagliavini, Fabrizio
    Ferrarese, Carlo
    DiFrancesco, Jacopo C.
    ANNALS OF NEUROLOGY, 2013, 73 (04) : 449 - 458
  • [47] Different clinical outcomes between cerebral amyloid angiopathy-related inflammation and non-inflammatory form
    Grangeon, L.
    Quesney, G.
    Verdalle-Cazes, M.
    Coulette, S.
    Renard, D.
    Wacongne, A.
    Allou, T.
    Olivier, N.
    Boukriche, Y.
    Blanchet-Fourcade, G.
    Labauge, P.
    Arquizan, C.
    Canaple, S.
    Godefroy, O.
    Martinaud, O.
    Verdure, P.
    Quillard-Muraine, M.
    Pariente, J.
    Magnin, E.
    Nicolas, G.
    Charbonnier, C.
    Maltete, D.
    Formaglio, M.
    Raposo, N.
    Ayrignac, X.
    Wallon, D.
    JOURNAL OF NEUROLOGY, 2022, 269 (09) : 4972 - 4984
  • [48] Diagnostic utility of amyloid PET in cerebral amyloid angiopathy-related symptomatic intracerebral hemorrhage
    Baron, Jean-Claude
    Farid, Karim
    Dolan, Eamon
    Turc, Guillaume
    Marrapu, Siva T.
    O'Brien, Eoin
    Aigbirhio, Franklin I.
    Fryer, Tim D.
    Menon, David K.
    Warburton, Elizabeth A.
    Hong, Young T.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2014, 34 (05) : 753 - 758
  • [49] Corticosteroids lead to short-term improvement in cerebral amyloid angiopathy-related inflammation
    Rempe, Torge
    Sollero, Carlos Eduardo Vervloet
    Rodriguez, Elsa
    Viswanathan, Vyas Tenkasi
    Carlson, Aaron
    Rees, John
    Tuna, Ibrahim Sacit
    Kresak, Jesse
    Gyang, Tirisham Victoria
    JOURNAL OF NEUROIMMUNOLOGY, 2020, 348
  • [50] Cerebrospinal Fluid, MRI, and Florbetaben-PET in Cerebral Amyloid Angiopathy-Related Inflammation
    Renard, Dimitri
    Collombier, Laurent
    Demattei, Christophe
    Wacongne, Anne
    Charif, Mahmoud
    Ayrignac, Xavier
    Azakri, Souhayla
    Gaillard, Nicolas
    Boudousq, Vincent
    Lehmann, Sylvain
    de Champfleur, Nicolas Menjot
    Thouvenot, Eric
    JOURNAL OF ALZHEIMERS DISEASE, 2018, 61 (03) : 1107 - 1117